tiprankstipranks
Trending News
More News >
CASI Pharmaceuticals (CASI)
NASDAQ:CASI

CASI Pharmaceuticals (CASI) Revenue

Compare
451 Followers

CASI Pharmaceuticals Revenue

CASI Pharmaceuticals had a revenue of 7.79M in the quarter ending Sep 30, 2024, with 95.85%. This bring the company's revenue in the last twelve months to 21.27M, Increased -4.68%. In the fiscal year ending Dec 31, 2024, CASI Pharmaceuticals had annual revenue of 28.54M with -15.77% growth.
Revenue (ttm)
21.27M
Revenue Growth
11.40%
P/S Ratio
0.72
Revenue/Employee
$122,476
Employees
233
Market Cap
$20.53M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
28.54M-5.34M-15.77%
Dec 31, 2023
33.88M-9.23M-21.41%
Dec 31, 2022
43.11M12.94M+42.89%
Dec 31, 2021
30.17M15.03M+99.25%
Dec 31, 2020
15.14M11.01M+266.52%
Dec 31, 2019
4.13M+∞%
Dec 31, 2018
0.00
Dec 31, 2017
0.00
Dec 31, 2016
0.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis